SHANA WHEELER: Open Payments
NPI 1275050387 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 58 payments from 19 companies in 2025. Trend: 2023 $1,346 · 2024 $1,164 · 2025 $1,293
Food & beverage: $1,293
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 19 | $465 |
| Merck Sharp & Dohme LLC | 6 | $179 |
| ABBVIE INC. | 4 | $106 |
| ViiV Healthcare Company | 4 | $102 |
| Lilly USA, LLC | 5 | $82 |
| Novo Nordisk Inc | 4 | $69 |
| TOLMAR, INC. | 3 | $55 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $23 |
| Bausch Health US, LLC | 1 | $22 |
Products named: PIFELTRO, VRAYLAR, MOUNJARO, DOVATO, Ozempic, JATENZO, CABENUVA, Dexcom G6 Transmitter.
Industry payments across AL — which companies pay providers there.
